164 related articles for article (PubMed ID: 17965073)
1. Reducing inflammation in COPD: the evidence builds.
Barnes N
Thorax; 2007 Nov; 62(11):927-8. PubMed ID: 17965073
[TBL] [Abstract][Full Text] [Related]
2. Ethanol extract of the tuber of Alisma orientale reduces the pathologic features in a chronic obstructive pulmonary disease mouse model.
Kim KH; Song HH; Ahn KS; Oh SR; Sadikot RT; Joo M
J Ethnopharmacol; 2016 Jul; 188():21-30. PubMed ID: 27154406
[TBL] [Abstract][Full Text] [Related]
3. Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways.
Li Q; Wang G; Xiong SH; Cao Y; Liu B; Sun J; Li L; Mohammadtursun N; Yu H; Dong J; Wu J
J Ethnopharmacol; 2020 Oct; 261():113095. PubMed ID: 32531410
[TBL] [Abstract][Full Text] [Related]
4. Why do we need a nonhuman primate model of smoking-induced COPD?
Curtis JL; Freeman CM
Am J Pathol; 2015 Mar; 185(3):610-3. PubMed ID: 25576784
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury.
Zhou F; Onizawa S; Nagai A; Aoshiba K
Respir Res; 2011 Jun; 12(1):78. PubMed ID: 21663649
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C).
Hubeau C; Kubera JE; Masek-Hammerman K; Williams CM
Clin Sci (Lond); 2013 Nov; 125(10):483-93. PubMed ID: 23738811
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease.
Haw TJ; Starkey MR; Pavlidis S; Fricker M; Arthurs AL; Nair PM; Liu G; Hanish I; Kim RY; Foster PS; Horvat JC; Adcock IM; Hansbro PM
Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L298-L317. PubMed ID: 29025711
[TBL] [Abstract][Full Text] [Related]
8. MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation.
Roffel MP; Maes T; Brandsma CA; van den Berge M; Vanaudenaerde BM; Joos GF; Brusselle GG; Heijink IH; Bracke KR
Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1091-L1104. PubMed ID: 34668437
[TBL] [Abstract][Full Text] [Related]
9. Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease.
Tsuji T; Aoshiba K; Nagai A
Respiration; 2010; 80(1):59-70. PubMed ID: 20016134
[TBL] [Abstract][Full Text] [Related]
10. Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.
Vlahos R; Bozinovski S
Methods Mol Biol; 2018; 1725():53-63. PubMed ID: 29322408
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?
Chen L; Liu L; Wang T; Shen YC; Wen FQ
Arch Med Res; 2013 Jan; 44(1):75-6. PubMed ID: 23287523
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: MicroRNA-150 in CS-induced lung inflammation.
Xue H; Li MX
Hum Exp Toxicol; 2018 Sep; 37(9):920-928. PubMed ID: 29205062
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
14. [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease].
Izquierdo JL; Almonacid C; Parra T; Pérez J
Arch Bronconeumol; 2006 Jul; 42(7):332-7. PubMed ID: 16945263
[TBL] [Abstract][Full Text] [Related]
15. Supplementing defect in club cell secretory protein attenuates airway inflammation in COPD.
Gamez AS; Gras D; Petit A; Knabe L; Molinari N; Vachier I; Chanez P; Bourdin A
Chest; 2015 Jun; 147(6):1467-1476. PubMed ID: 25474370
[TBL] [Abstract][Full Text] [Related]
16. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
Kharitonov SA
Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
[TBL] [Abstract][Full Text] [Related]
17. No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease.
Yayan J
Int J Med Sci; 2015; 12(3):280-7. PubMed ID: 25798054
[TBL] [Abstract][Full Text] [Related]
18. The neutrophil in chronic obstructive pulmonary disease.
Hoenderdos K; Condliffe A
Am J Respir Cell Mol Biol; 2013 May; 48(5):531-9. PubMed ID: 23328639
[TBL] [Abstract][Full Text] [Related]
19. Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury.
Gao W; Yuan C; Zhang J; Li L; Yu L; Wiegman CH; Barnes PJ; Adcock IM; Huang M; Yao X
Clin Sci (Lond); 2015 Dec; 129(12):1011-23. PubMed ID: 26201096
[TBL] [Abstract][Full Text] [Related]
20. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
